Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose

被引：12

作者：

Biedunkiewicz, Bogdan ^{[1
]}

Tylicki, Leszek ^{[1
]}

Slizien, Waldemar ^{[2
]}

Lichodziejewska-Niemierko, Monika ^{[1
]}

Dabrowska, Malgorzata ^{[3
]}

Kubanek, Alicja ^{[4
]}

Rodak, Sylwia ^{[2
]}

Polewska, Karolina ^{[1
,5
]}

Tylicki, Piotr ^{[1
,5
]}

Renke, Marcin ^{[4
]}

Debska-Slizien, Alicja ^{[1
]}

机构：

[1] Med Univ Gdansk, Dept Nephrol Transplantol & Internal Med, PL-80210 Gdask, Poland

[2] NZOZ Diaverum, PL-81519 Gdynia, Poland

[3] Univ Clin Ctr, Cent Clin Lab, PL-80952 Gdansk, Poland

[4] Med Univ Gdansk, Dept Occupat Metab & Internal Dis, PL-81519 Gdynia, Poland

[5] Med Univ Gdansk, Gdansk, Poland

来源：

VACCINES | 2022年 / 10卷 / 03期

关键词：

COVID-19; SARS-CoV-2; maintenance dialysis patients; mRNA vaccines; humoral immunity; seroconversion; SARS-COV-2; MORTALITY; IMMUNITY; BNT162B2;

D O I：

10.3390/vaccines10030433

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The aim of this study was to analyze the waning of anti-spike (S) antibodies after mRNA vaccination against COVID-19 in maintenance dialysis patients, and to assess the safety and effectiveness of the complementary third dose. This was a prospective, longitudinal study in which we analyzed the kinetics of antibodies up to six months after a two-dose vaccination (first protocol) in infection-naive dialysis patients (IN-Ds), previously infected dialysis patients (PI-Ds) and subjects without chronic kidney disease (the controls), as well as their humoral response to the third dose of the same mRNA vaccine (second protocol). The respective reduction in antibody titer after 3 and 6 months by 82.9% and 93.03% in IN-Ds (n = 109), 73.4% and 93.36% in PI-Ds (n = 32) and 75.5% and 88.8% in the controls (n = 20) was demonstrated. Consequently, a protective antibody titer above 141 BAU/mL was found in only 47.7% and 23.8% of IN-Ds after 3 and 6 months, respectively. After the third vaccine dose, a significant increase in antibody titer was observed in all groups, with increases by a factor of 51.6 in IN-Ds, 30.1 in the controls and 8.4 in PI-Ds. The median antibody titer after the third dose differed significantly between groups, and was the highest in PI-Ds: PI-Ds, 9090 (3300-15,000) BAU/mL; the controls, 6945 (2130-11,800); IN-Ds, 3715 (1470-7325) (p < 0.001). In conclusion, we observed similar degrees of antibody waning in all patients. After 3 months, over half of the infection-naive dialysis patients had a very low antibody titer, and almost twenty percent of them had no antibodies at all. The humoral response to the third dose was very good, raising their titer of antibodies to a higher level than those in the general population who have received the primary two-dose scheme. The results support the administration of a complementary third dose of the mRNA vaccine for dialysis patients as soon as possible.

引用

页数：12

共 33 条

[1] Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients [J].

Amodio, Emanuele ;

Capra, Giuseppina ;

Casuccio, Alessandra ;

De Grazia, Simona ;

Genovese, Dario ;

Pizzo, Stefano ;

Calamusa, Giuseppe ;

Ferraro, Donatella ;

Giammanco, Giovanni Maurizio ;

Vitale, Francesco ;

Bonura, Floriana .

VACCINES, 2021, 9 (07)

[2] Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis [J].

Anand, Shuchi ;

Montez-Rath, Maria E. ;

Han, Jialin ;

Garcia, Pablo ;

Cadden, LinaCel ;

Hunsader, Patti ;

Kerschmann, Russell ;

Beyer, Paul ;

Boyd, Scott D. ;

Chertow, Glenn M. ;

Parsonnet, Julie .

ANNALS OF INTERNAL MEDICINE, 2021, 174 (08) :1073-+

[3] Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study [J].

Barda, Noam ;

Dagan, Noa ;

Cohen, Cyrille ;

Hernan, Miguel A. ;

Lipsitch, Marc ;

Kohane, Isaac S. ;

Reis, Ben Y. ;

Balicer, Ran D. .

LANCET, 2021, 398 (10316) :2093-2100

[4] Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers [J].

Bayart, Jean-Louis ;

Douxfils, Jonathan ;

Gillot, Constant ;

David, Clara ;

Mullier, Francois ;

Elsen, Marc ;

Eucher, Christine ;

Van Eeckhoudt, Sandrine ;

Roy, Tatiana ;

Gerin, Vincent ;

Wieers, Gregoire ;

Laurent, Christine ;

Closset, Melanie ;

Dogne, Jean-Michel ;

Favresse, Julien .

VACCINES, 2021, 9 (10)

[5] SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis [J].

Bensouna, Ilias ;

Caudwell, Valerie ;

Kubab, Sabah ;

Acquaviva, Sandra ;

Pardon, Agathe ;

Vittoz, Nathalie ;

Bozman, Dogan-Firat ;

Hanafi, Latifa ;

Faucon, Anne -Laure ;

Housset, Pierre .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (02) :185-+

[6] Defining 'T cell exhaustion' [J].

Blank, Christian U. ;

Haining, W. Nicholas ;

Held, Werner ;

Hogan, Patrick G. ;

Kallies, Axel ;

Lugli, Enrico ;

Lynn, Rachel C. ;

Philip, Mary ;

Rao, Anjana ;

Restifo, Nicholas P. ;

Schietinger, Andrea ;

Schumacher, Ton N. ;

Schwartzberg, Pamela L. ;

Sharpe, Arlene H. ;

Speiser, Daniel E. ;

Wherry, E. John ;

Youngblood, Benjamin A. ;

Zehn, Dietmar .

NATURE REVIEWS IMMUNOLOGY, 2019, 19 (11) :665-674

[7] Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies [J].

Bonelli, Fabrizio ;

Blocki, Frank A. ;

Bunnell, Tina ;

Chu, Edward ;

De La, Arriel O. ;

Grenache, David G. ;

Marzucchi, Ginevra ;

Montomoli, Emanuele ;

Okoye, Lilian ;

Pallavicini, Luca ;

Streva, Vincent A. ;

Torelli, Alessandro ;

Wagner, Aaron ;

Zanin, Davide ;

Zierold, Claudia ;

Wassenberg, James J. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (08) :1463-1467

[8] Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization [J].

Bonura, Floriana ;

De Grazia, Simona ;

Bonura, Celestino ;

Sanfilippo, Giuseppa L. ;

Giammanco, Giovanni M. ;

Amodio, Emanuele ;

Ferraro, Donatella .

JOURNAL OF APPLIED MICROBIOLOGY, 2022, 132 (05) :3987-3994

[9] SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers [J].

Boulanger, Henri ;

Saksi, Salima Ahriz ;

Achiche, Jedjiga ;

Batusanski, Florence ;

Stawiarski, Nicolas ;

Diddaoui, Ali ;

Fromentin, Luc ;

Chawki, Mokhtar .

INTERNATIONAL JOURNAL OF NEPHROLOGY, 2021, 2021

[10] Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost [J].

Davidovic, Tamara ;

Schimpf, Judith ;

Abbassi-Nik, Armin ;

Stockinger, Richard ;

Sprenger-Maehr, Hannelore ;

Lhotta, Karl ;

Zitt, Emanuel .

KIDNEY INTERNATIONAL, 2021, 100 (06) :1334-1335

← 1 2 3 4 →